Preview

Ranbaxy Laboratories

Good Essays
Open Document
Open Document
759 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Ranbaxy Laboratories
Ranbaxy Laboratories Ltd. (RLL) is the largest pharmaceutical company incorporated in India. It is also amongst the top league globally and is ranked 9th largest generic company worldwide. Ranbaxy is also credited with the tag of true Indian multinational. The company traces its roots to a chemist shop in Delhi. It is one of the first Indian pharmaceutical company to start a joint venture abroad. Rapid growth of Ranbaxy is attributed mainly to its focused research and joint ventures in India and abroad. It is also innovation and market driven, with a strong distribution network. The company was able to grow successfully in highly competitive markets. In the current business scenario, Ranbaxy is focusing on innovation, alliances, mergers and globalisation to achieve its long-term vision of becoming a global pharmaceutical giant with a turnover of $1 billion by 2004. The fruits of such efforts are evident in the latest financial result, as a large chunk of its income comes from new products and exports of generics. The growth of Ranbaxy can be attributed to its ability to identify good windows of opportunity and its ability to grow by leveraging innovation, regulatory knowledge and alliances.

Introduction - Business Opportunities with Ranbaxy: Core Competencies

|[pic] |

Ranbaxy Pharmaceuticals Inc. (RPI) has already experienced commercial success penetrating the U.S. health care market, and is looking to enhance growth and future business opportunities through collaboration and strategic alliances.

Ranbaxy Pharmaceuticals Inc. (RPI) is a product-driven pharmaceutical company with diversified expertise. As a wholly owned subsidiary of Ranbaxy Laboratories Limited, India’s largest pharmaceutical company, RPI offers an advantage of having a global presence with experience in more than 125 international markets.

The company’s advanced product development and manufacturing capabilities, combined with a global sales and
Continue Reading
View Writing Issues

You May Also Find These Documents Helpful

  • Powerful Essays

    Teva Pharmacuetical
    • 2882 Words
    • 12 Pages

    Teva Pharmacuetical

    More than 100 years ago Teva Pharmaceuticals opened their doors as a wholesale drug distributor in Jerusalem. Today they have become the world’s leading producer of generic pharmaceuticals. Revenue has grown from $91 million in 1985 to $8.5 billion in 2006. This growth has not been easy and derives from key strategic decisions made along the way in order to amass these huge dollars amounts. Teva’s mission is to play a leading role in the transformation of the healthcare system through the development, manufacture and marketing of generic pharmaceuticals. Teva’s organizational structure is a symbol of their fundamental business strategy, highlighting their global strength and pharmaceutical diversity. This allows them to continue to expand their core generic business across all geographies and leverage their global reach and scientific strength to develop new innovative products and technologies. Teva has picked an industry in which there will always be a need, medicine. However, it is their approach to prescription medicine that will decide the future of Teva.…

    • 2882 Words
    • 12 Pages
    Powerful Essays
    Read More
  • Powerful Essays

    Financial Analysis of Merck and Pfizer
    • 3675 Words
    • 15 Pages

    Financial Analysis of Merck and Pfizer

    Strategy: Pfizer is the world’s number one pharmaceutical company. Its best-selling products include Lipitor, the world’s best- selling medicine, and eight of the top twenty-five medicines in the world. Acquisition of successful competitors such as Pharmacia and Warner Lambert has helped Pfizer to offer best-selling products and further differentiate itself from competitors. The acquisition of the latter company helped bring Lipitor under Pfizer’s control.…

    • 3675 Words
    • 15 Pages
    Powerful Essays
    Read More
  • Powerful Essays

    The Financial Detective, 2005
    • 2519 Words
    • 11 Pages

    The Financial Detective, 2005

    | This firm is the world’s largest prescription-pharmaceutical company, and has a very broad and deep pipeline of ethical pharmaceutical, supported by robust research and development budget. The company has divested several of its non-pharmaceutical businesses, and become the partner of choice for licensing deals with other pharmaceutical and biotechnology firms…

    • 2519 Words
    • 11 Pages
    Powerful Essays
    Read More
  • Good Essays

    Eli Lilly – Ranbaxy Case Project
    • 1614 Words
    • 7 Pages

    Eli Lilly – Ranbaxy Case Project

    Eli Lilly would establish a presence in the region and gain access to the distribution network enjoyed by Ranbaxy. Furthermore, this JV would result in lower costs in production as well as basic research, which are considerable factors in their broad strategy. The evolution of the international joint venture was strategically handled with early success, starting off with the name of the company, Eli Lilly Ranbaxy; it was strategically named…

    • 1614 Words
    • 7 Pages
    Good Essays
    Read More
  • Good Essays

    Bristol Meyers Squibb vs Takeda
    • 1033 Words
    • 5 Pages

    Bristol Meyers Squibb vs Takeda

    Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers’ needs, giving maximum priority to accelerating pipeline development, delivering sales growth and continuing to manage costs. Around the world, our medicines help millions of people in their fight against cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis and psychiatric disorders.…

    • 1033 Words
    • 5 Pages
    Good Essays
    Read More
  • Powerful Essays

    Hbr Vertex Case Critique
    • 1920 Words
    • 8 Pages

    Hbr Vertex Case Critique

    However, as the industry was entering 21st century, it was also facing couple of challenges: Firstly, companies started to experience a declining productivity in their R&D pipelines. Secondly, there were concerns being raised about the increasing cost of health care in recent years. Lastly, new laws and regulations are being introduced in patent protection and clinical testing areas. As a result of these factors, big Pharmaceutical companies were switching their preferences from entering early stage research partnerships to alliances for drug candidates that have more and promising clinical data.…

    • 1920 Words
    • 8 Pages
    Powerful Essays
    Read More
  • Powerful Essays

    Sigma Pharmaceuticals Essay
    • 4332 Words
    • 18 Pages

    Sigma Pharmaceuticals Essay

    The report then puts forward two diverse strategies– one to enter into the Chinese pharmaceutical market via a joint venture and the other is to enter into a new market segment; biotechnology.…

    • 4332 Words
    • 18 Pages
    Powerful Essays
    Read More
  • Good Essays

    1968
    • 714 Words
    • 3 Pages

    1968

    The year 1968 is considered one of the most turbulent, and pivotal, twelve month periods in American history. This single year was a flashpoint for many of the social, political, and cultural transformations for which the overall decade of the 1960s is known. During these years, the United States became entrenched in an unpopular war in Vietnam abroad, while unrest, experimentation, violence, and outspokenness raged throughout the nation. The Civil Rights Movement gained momentum, sit-ins and riots became commonplace, leaders were assassinated on a seemingly regular basis, and social experimentation and psychedelic music became the rage in San Francisco and elsewhere.…

    • 714 Words
    • 3 Pages
    Good Essays
    Read More
  • Best Essays

    Impact of Lipitor Patent Expiry on Pfizer.
    • 4183 Words
    • 17 Pages

    Impact of Lipitor Patent Expiry on Pfizer.

    narayan, a. e. (2011, december 01). ranbaxy lipitor copy in us stores threatens pfizer sales. Retrieved december 10, 2011, from businessweek.com: busineesweek.com/news/2011-12-01/ranbaxy-s-lipitor-copy-in-u-s-stores-threatens-pfizer-sales.html…

    • 4183 Words
    • 17 Pages
    Best Essays
    Read More
  • Good Essays

    Eli Lilly in India: Rethinking the Joint Venture Strategy
    • 426 Words
    • 2 Pages

    Eli Lilly in India: Rethinking the Joint Venture Strategy

    No, deciding to partner was not wrong. Lilly was a name that most Indian people did not recognize. However, Ranbaxy was the leader in India. Lilly could use Ranbaxy’s name to make Indian people know it. In addition, Lilly could use their distribution network. Ranbaxy’s help was used for getting government approvals and licenses. Partnership probably is good. In the case, Lilly utilized many advantages from Ranbaxy, so the partnership with Ranbaxy was helpful for Lilly.…

    • 426 Words
    • 2 Pages
    Good Essays
    Read More
  • Good Essays

    Pharma Update 08 Nov 2014
    • 766 Words
    • 3 Pages

    Pharma Update 08 Nov 2014

    USFDA revokes Ranbaxy's 180-day exclusivity on sale of two generic drugs in US, grants approval to Dr. Reddy for one of them…

    • 766 Words
    • 3 Pages
    Good Essays
    Read More
  • Satisfactory Essays

    Eli Lilly Case
    • 552 Words
    • 3 Pages

    Eli Lilly Case

    Eli Lilly was a recognized brand United States. However, that was not the case in India. Ranbaxy was the leader company within in India, which gave competitive advantage to the Eli Lilly Ranbaxy JV. After reviewing the case, I feel that without the facilitation of the Joint venture, Eli Lilly may not have been as successful operating in the India market. Higher capital investment would have been necessary, which in return would have meant higher risk of loss and a lot more time before reaching the break-even point. The Eli Lilly Ranbaxy joint venture allowed Eli Lilly to acquire brand recognition, establish a corporate culture, facilitated distribution and government procedures, minimized errors, and lessened risk. The case recalled Gulati: “We used Ranbaxy’s name for everything. We were new and it was very difficult for us…” which heavily reflects the advantages of the joint venture with Ranbaxy. Such factors had a great influence in the success of the Eli Lilly’s company in India, which is why I believe that Eli Lilly pursued the right strategy to enter the Indian market.…

    • 552 Words
    • 3 Pages
    Satisfactory Essays
    Read More
  • Satisfactory Essays

    Eli Lily Case Study
    • 489 Words
    • 2 Pages

    Eli Lily Case Study

    It was a right strategy for Eli Lilly that started a joint venture with Ranbaxy to enter the Indian market. First of all, Ranbaxy was the second largest pharmaceutical company that manufactures bulk drugs and generic drugs in India, with a domestic market share of 15 per cent. It had established broad distribution network, and it was the second largest exporter of all products in India. Ranbaxy’s capital costs were 50 per cent to 75 per cent lower than those of comparable U.S. plants. Second, the timing was perfect for Eli Lilly to enter the Indian market. During 1970s, the Patents Act 1970 and the Drug Price Control Order (DPCO) was issued. And India was opening its drug market. Third, there was possibility to conduct cheap clinical trials in India.…

    • 489 Words
    • 2 Pages
    Satisfactory Essays
    Read More
  • Good Essays

    Innovation Description of Rtc and the Outcome
    • 513 Words
    • 3 Pages

    Innovation Description of Rtc and the Outcome

    In my opinion, I prefer to describe RTC as a ‘Blue Sky Innovator’. The reason is that it is relatively autonomy from the Pfizer and the employees there enjoyed creative and flexible research environment. To some extent, it has worked successfully since it has created several drugs per year, and its managerial style has attracted many scientists to join it. It even provide free innovation network for all the sites of Pfizer. However, it has also put itself into a passive position, which resulted in many challenges. This is because it was fully founded by Pfizer, which make them has less authority to manage its employees, which made it hard to recruit new scientists from top universities like Cambridge. The other challenge is that they could not easily convince headquarters of Pfizer to try their new drugs or listen to their presentations. The final challenge is that the ambiguity of mission makes both leaders and employees confused of their goals, which may lead to unsuccessful future.…

    • 513 Words
    • 3 Pages
    Good Essays
    Read More
  • Satisfactory Essays

    CASE STUDY : BRISTOL-MEYERS SQUIBB 2011
    • 1397 Words
    • 9 Pages

    CASE STUDY : BRISTOL-MEYERS SQUIBB 2011

    Headquartered in New York City, Bristol-Myers Squibb is a huge pharmaceutical firm with such blockbuster cardiovascular drugs as Plavix and Avapro for hypertension. BMY also produces antipsychotic medication Abilify and HIV treatments Reyataz and Sustiva. BMY also has excellent products in immunoscience, metabolics, neuroscience, oncology, and virology. BMY has 12 manufacturing plants worldwide and conducts research and development in four countries, sells its products globally; the US accounts for two thirds of BMY’s sales. The year 2011 has been fruitful for Bristol-Myers with many key drugs getting approved as the company aims to combat the pendeng genericization of some of its key drugs including the blockbuster blood-thinner Plavix. BMY has an excellent pipeline of drugs that should get approved in the next twelve months.…

    • 1397 Words
    • 9 Pages
    Satisfactory Essays
    Read More

Related Topics